Daito Pharmaceutical Co Ltd
TSE:4577

Watchlist Manager
Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd
TSE:4577
Watchlist
Price: 2 124 JPY -1.12% Market Closed
Market Cap: 32.5B JPY
Have any thoughts about
Daito Pharmaceutical Co Ltd?
Write Note

Daito Pharmaceutical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Daito Pharmaceutical Co Ltd
Operating Income Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Daito Pharmaceutical Co Ltd
TSE:4577
Operating Income
ÂĄ3.7B
CAGR 3-Years
-17%
CAGR 5-Years
-5%
CAGR 10-Years
2%
Takeda Pharmaceutical Co Ltd
TSE:4502
Operating Income
ÂĄ403B
CAGR 3-Years
-17%
CAGR 5-Years
13%
CAGR 10-Years
12%
Daiichi Sankyo Co Ltd
TSE:4568
Operating Income
ÂĄ260.5B
CAGR 3-Years
51%
CAGR 5-Years
19%
CAGR 10-Years
7%
Otsuka Holdings Co Ltd
TSE:4578
Operating Income
ÂĄ353.6B
CAGR 3-Years
19%
CAGR 5-Years
33%
CAGR 10-Years
5%
Chugai Pharmaceutical Co Ltd
TSE:4519
Operating Income
ÂĄ540.2B
CAGR 3-Years
15%
CAGR 5-Years
24%
CAGR 10-Years
21%
Astellas Pharma Inc
TSE:4503
Operating Income
ÂĄ130.6B
CAGR 3-Years
-1%
CAGR 5-Years
-13%
CAGR 10-Years
-1%

See Also

What is Daito Pharmaceutical Co Ltd's Operating Income?
Operating Income
3.7B JPY

Based on the financial report for Aug 31, 2024, Daito Pharmaceutical Co Ltd's Operating Income amounts to 3.7B JPY.

What is Daito Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
2%

Over the last year, the Operating Income growth was -23%. The average annual Operating Income growth rates for Daito Pharmaceutical Co Ltd have been -17% over the past three years , -5% over the past five years , and 2% over the past ten years .

Back to Top